Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG:

KY1043

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Company:

Sanofi

Drug class:

PD-L1 inhibitor, IL-2 stimulant

Related drugs:

‹

IL2-L19-TNF (0)

STAR-LLD SC (0)

atezolizumab (236)

durvalumab (199)

benmelstobart (12)

sugemalimab (7)

envafolimab (6)

IO102-IO103 (4)

socazolimab (2)

atezolizumab and hyaluronidase-tqjs (1)

adebrelimab (0)

CF33-hNIS-antiPDL1 (0)

PD-L1.t-haNK (0)

PF-07257876 (0)

Undisclosed anti-PD-L1 antibody (0)

cosibelimab-ipdl (0)

denileukin diftitox (4)

aldesleukin (2)

denileukin diftitox-cxdl (1)

celmoleukin (0)

DI Leu16 IL-2 (0)

leukocyte interleukin injection (0)

PF-06753512 (0)

PSA/IL-2/GM-CSF vaccine (0)

STK-009/SYNCAR-001 (0)

attenuated Salmonella typhimurium expressing IL-2 (0)

IL2-L19-TNF (0)

STAR-LLD SC (0)

›